---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-016227"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:39:30.251164+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# PAVmed subsidiary Veris Health raises $2.5M in equity and warrant offering

## Summary
- Veris sold 1,785,714 common shares and warrants at $1.40 per share unit.
- Gross proceeds of ~$2.5M for development of implantable physiological monitor and working capital.
- After offering, PAVmed owns 75.3% of Veris on a fully-diluted basis.
- Warrants exercisable after 6 months at $1.40, expire 5 years from exercise or 60 days post-FDA approval.
- Investors granted anti-dilution protection and 100% participation rights in future equity raises.

## SEC filing metadata
- accession: 0001641172-25-016227
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000164117225016227/0001641172-25-016227-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000164117225016227/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-016227
- JSON: https://secwatch.observer/filing/0001641172-25-016227.json
- Plain text: https://secwatch.observer/filing/0001641172-25-016227.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.